1. Home
  2. LPCN vs OCEA Comparison

LPCN vs OCEA Comparison

Compare LPCN & OCEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • OCEA
  • Stock Information
  • Founded
  • LPCN 1997
  • OCEA 2019
  • Country
  • LPCN United States
  • OCEA United States
  • Employees
  • LPCN N/A
  • OCEA N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • OCEA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LPCN Health Care
  • OCEA Health Care
  • Exchange
  • LPCN Nasdaq
  • OCEA Nasdaq
  • Market Cap
  • LPCN 36.8M
  • OCEA 30.4M
  • IPO Year
  • LPCN N/A
  • OCEA N/A
  • Fundamental
  • Price
  • LPCN $4.71
  • OCEA $0.69
  • Analyst Decision
  • LPCN Strong Buy
  • OCEA
  • Analyst Count
  • LPCN 1
  • OCEA 0
  • Target Price
  • LPCN $10.00
  • OCEA N/A
  • AVG Volume (30 Days)
  • LPCN 28.3K
  • OCEA 44.7K
  • Earning Date
  • LPCN 11-07-2024
  • OCEA 12-03-2024
  • Dividend Yield
  • LPCN N/A
  • OCEA N/A
  • EPS Growth
  • LPCN N/A
  • OCEA N/A
  • EPS
  • LPCN N/A
  • OCEA N/A
  • Revenue
  • LPCN $7,922,926.00
  • OCEA N/A
  • Revenue This Year
  • LPCN N/A
  • OCEA N/A
  • Revenue Next Year
  • LPCN N/A
  • OCEA N/A
  • P/E Ratio
  • LPCN N/A
  • OCEA N/A
  • Revenue Growth
  • LPCN N/A
  • OCEA N/A
  • 52 Week Low
  • LPCN $2.38
  • OCEA $0.52
  • 52 Week High
  • LPCN $11.79
  • OCEA $7.79
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 41.11
  • OCEA 32.02
  • Support Level
  • LPCN $4.64
  • OCEA $0.65
  • Resistance Level
  • LPCN $4.98
  • OCEA $0.74
  • Average True Range (ATR)
  • LPCN 0.51
  • OCEA 0.06
  • MACD
  • LPCN -0.12
  • OCEA -0.01
  • Stochastic Oscillator
  • LPCN 5.12
  • OCEA 16.00

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.

About OCEA Ocean Biomedical Inc.

Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.

Share on Social Networks: